Vanguard Personalized Indexing Management
DXCM icon

Vanguard Personalized Indexing Management’s DexCom DXCM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
35,508
+751
+2% +$50K 0.02% 579
2026
Q1 		$2.18M Buy
34,757
+3,429
+11% +$239K 0.02% 569
2025
Q4 		$2.08M Sell
31,328
-5,713
-15% -$369K 0.02% 582
2025
Q3 		$2.49M Sell
37,041
-7,219
-16% -$571K 0.03% 514
2025
Q2 		$3.86M Buy
44,260
+5,763
+15% +$452K 0.04% 359
2025
Q1 		$2.63M Sell
38,497
-1,254
-3% -$102K 0.04% 407
2024
Q4 		$3.09M Buy
39,751
+5,700
+17% +$422K 0.05% 340
2024
Q3 		$2.28M Sell
34,051
-5,355
-14% -$440K 0.04% 431
2024
Q2 		$4.46M Sell
39,406
-1,110
-3% -$140K 0.08% 198
2024
Q1 		$5.62M Buy
40,516
+2,544
+7% +$320K 0.12% 151
2023
Q4 		$4.71M Buy
37,972
+983
+3% +$100K 0.12% 144
2023
Q3 		$3.45M Sell
36,989
-2,181
-6% -$246K 0.1% 183
2023
Q2 		$5.03M Buy
39,170
+2,164
+6% +$262K 0.15% 110
2023
Q1 		$4.3M Buy
37,006
+5,493
+17% +$615K 0.15% 118
2022
Q4 		$3.57M Buy
31,513
+9,692
+44% +$1.06M 0.15% 131
2022
Q3 		$1.76M Buy
21,821
+8,214
+60% +$696K 0.08% 258
2022
Q2 		$1.01M Buy
13,607
+1,331
+11% +$121K 0.05% 455
2022
Q1 		$1.57M Buy
12,276
+3,200
+35% +$350K 0.08% 258
2021
Q4 		$1.22M Buy
9,076
+3,024
+50% +$435K 0.07% 306
2021
Q3 		$827K Buy
6,052
+2,304
+61% +$291K 0.07% 285
2021
Q2 		$400K Sell
3,748
-2,848
-43% -$274K 0.04% 597
2021
Q1 		$593K Buy
6,596
+2,672
+68% +$251K 0.09% 268
2020
Q4 		$363K Buy
3,924
+340
+9% +$30.4K 0.08% 297
2020
Q3 		$369K Buy
3,584
+544
+18% +$56.8K 0.1% 235
2020
Q2 		$308K Buy
+3,040
New +$272K 0.14% 182

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Personalized Indexing Management's DXCM Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its DexCom (DXCM) stake by 2.2% in Q2 2026, buying an estimated $50K and bringing the position to 35,508 shares worth $2.39M. The position accounts for 0.02% of the portfolio, ranked #579.

Vanguard Personalized Indexing Management first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.62M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vanguard Personalized Indexing Management held 35,508 shares of DexCom worth $2.39M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 751 DexCom shares in Q2 2026, an estimated $50K.
  • DexCom made up 0.02% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #579 holding.
  • Vanguard Personalized Indexing Management first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Vanguard Personalized Indexing Management's DexCom position peaked at $5.62M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.